Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Entrada Therapeutics (TRDA) Change in Taxes (2023 - 2025)

Entrada Therapeutics has reported Change in Taxes over the past 3 years, most recently at -$620000.0 for Q4 2025.

  • Quarterly results put Change in Taxes at -$620000.0 for Q4 2025, up 60.86% from a year ago — trailing twelve months through Dec 2025 was -$667000.0 (up 80.13% YoY), and the annual figure for FY2025 was -$667000.0, up 80.13%.
  • Change in Taxes for Q4 2025 was -$620000.0 at Entrada Therapeutics, down from $620000.0 in the prior quarter.
  • Over the last five years, Change in Taxes for TRDA hit a ceiling of $7.4 million in Q2 2023 and a floor of -$7.4 million in Q3 2023.
  • Median Change in Taxes over the past 3 years was -$620000.0 (2025), compared with a mean of $0.0.
  • Biggest five-year swings in Change in Taxes: crashed 139.36% in 2024 and later surged 133.33% in 2025.
  • Entrada Therapeutics' Change in Taxes stood at $4.0 million in 2023, then crashed by 139.36% to -$1.6 million in 2024, then soared by 60.86% to -$620000.0 in 2025.
  • The last three reported values for Change in Taxes were -$620000.0 (Q4 2025), $620000.0 (Q3 2025), and -$802000.0 (Q2 2025) per Business Quant data.